GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scancell Holdings PLC (AQSE:SCLP.GB) » Definitions » Liabilities-to-Assets

Scancell Holdings (AQSE:SCLP.GB) Liabilities-to-Assets : 1.38 (As of Oct. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Scancell Holdings Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Scancell Holdings's Total Liabilities for the quarter that ended in Oct. 2023 was £30.62 Mil. Scancell Holdings's Total Assets for the quarter that ended in Oct. 2023 was £22.25 Mil. Therefore, Scancell Holdings's Liabilities-to-Assets Ratio for the quarter that ended in Oct. 2023 was 1.38.


Scancell Holdings Liabilities-to-Assets Historical Data

The historical data trend for Scancell Holdings's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scancell Holdings Liabilities-to-Assets Chart

Scancell Holdings Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.13 0.82 0.88 1.21

Scancell Holdings Semi-Annual Data
Apr14 Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.88 0.60 1.21 1.38

Competitive Comparison of Scancell Holdings's Liabilities-to-Assets

For the Biotechnology subindustry, Scancell Holdings's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scancell Holdings's Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scancell Holdings's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Scancell Holdings's Liabilities-to-Assets falls into.



Scancell Holdings Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Scancell Holdings's Liabilities-to-Assets Ratio for the fiscal year that ended in Apr. 2023 is calculated as:

Liabilities-to-Assets (A: Apr. 2023 )=Total Liabilities/Total Assets
=36.503/30.27
=1.21

Scancell Holdings's Liabilities-to-Assets Ratio for the quarter that ended in Oct. 2023 is calculated as

Liabilities-to-Assets (Q: Oct. 2023 )=Total Liabilities/Total Assets
=30.615/22.252
=1.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Scancell Holdings  (AQSE:SCLP.GB) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Scancell Holdings Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Scancell Holdings's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Scancell Holdings (AQSE:SCLP.GB) Business Description

Traded in Other Exchanges
Address
Sanders Road, Unit 202, Bellhouse Building, Oxford Science Park, Oxford, GBR, OX4 4GD
Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

Scancell Holdings (AQSE:SCLP.GB) Headlines

No Headlines